| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R)
|
Bolignano, Davide
|
|
2010
|
28 |
6 |
p. 642-647
6 p.
|
artikel
|
| 2 |
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
|
Hanke, Merle
|
|
2010
|
28 |
6 |
p. 655-661
7 p.
|
artikel
|
| 3 |
Asian robotic experience
|
Sundram, Murali
|
|
2010
|
28 |
6 |
p. 677-681
5 p.
|
artikel
|
| 4 |
Cancer stem cells in urologic cancers
|
Gedye, Craig
|
|
2010
|
28 |
6 |
p. 585-590
6 p.
|
artikel
|
| 5 |
Commentary on “Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: Diagnostic review bias in the randomized, prospective CEFUB trial”
|
See, William
|
|
2010
|
28 |
6 |
p. 696-
1 p.
|
artikel
|
| 6 |
Commentary on “Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria”
|
See, William
|
|
2010
|
28 |
6 |
p. 696-697
2 p.
|
artikel
|
| 7 |
Commentary on “Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy”?
|
See, William
|
|
2010
|
28 |
6 |
p. 695-
1 p.
|
artikel
|
| 8 |
Commentary on “The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer”
|
See, William
|
|
2010
|
28 |
6 |
p. 694-
1 p.
|
artikel
|
| 9 |
Contents
|
|
|
2010
|
28 |
6 |
p. iii-v
nvt p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2010
|
28 |
6 |
p. i-
1 p.
|
artikel
|
| 11 |
Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells
|
Qu, Wei
|
|
2010
|
28 |
6 |
p. 648-654
7 p.
|
artikel
|
| 12 |
Facilitating large-scale clinical trials: In Asia
|
Choi, Han Yong
|
|
2010
|
28 |
6 |
p. 691-692
2 p.
|
artikel
|
| 13 |
Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project)
|
Roobol, M.J.
|
|
2010
|
28 |
6 |
p. 686-690
5 p.
|
artikel
|
| 14 |
Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine
|
Lin, Hui-Hui
|
|
2010
|
28 |
6 |
p. 597-602
6 p.
|
artikel
|
| 15 |
Laparoscopic approach to small renal mass
|
Teh, Guan Chou
|
|
2010
|
28 |
6 |
p. 682-685
4 p.
|
artikel
|
| 16 |
Mass screening of prostate cancer in Vietnam: Current status and our opinions
|
Vu Le, Chuyen
|
|
2010
|
28 |
6 |
p. 673-676
4 p.
|
artikel
|
| 17 |
Masthead
|
|
|
2010
|
28 |
6 |
p. vi-
1 p.
|
artikel
|
| 18 |
Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer
|
dos Reis, Sabrina Thalita
|
|
2010
|
28 |
6 |
p. 624-627
4 p.
|
artikel
|
| 19 |
Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors
|
Pectasides, Dimitrios
|
|
2010
|
28 |
6 |
p. 617-623
7 p.
|
artikel
|
| 20 |
MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL
|
Lu, Qiang
|
|
2010
|
28 |
6 |
p. 635-641
7 p.
|
artikel
|
| 21 |
Opium consumption and risk of bladder cancer: A case-control analysis
|
Hosseini, Seyyed Yousof
|
|
2010
|
28 |
6 |
p. 610-616
7 p.
|
artikel
|
| 22 |
Prostate cancer around the world. An overview
|
Schröder, Fritz H.
|
|
2010
|
28 |
6 |
p. 663-667
5 p.
|
artikel
|
| 23 |
Prostate cancer screening perspective, Malaysia
|
Sothilingam, Selvalingam
|
|
2010
|
28 |
6 |
p. 670-672
3 p.
|
artikel
|
| 24 |
Renal cell carcinoma with inferior vena cava thrombus: The Hacettepe experience
|
Yazici, Sertac
|
|
2010
|
28 |
6 |
p. 603-609
7 p.
|
artikel
|
| 25 |
Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers
|
Bruyere, Franck
|
|
2010
|
28 |
6 |
p. 591-596
6 p.
|
artikel
|
| 26 |
Survey Section Editorial Board
|
|
|
2010
|
28 |
6 |
p. 693-
1 p.
|
artikel
|
| 27 |
Survival analysis in men undergoing radical prostatectomy at an age of 70 years or older
|
Froehner, Michael
|
|
2010
|
28 |
6 |
p. 628-634
7 p.
|
artikel
|
| 28 |
The future of urologic cancer care in the United States: Our finest hour or a bridge too far
|
Loughlin, Kevin R.
|
|
2010
|
28 |
6 |
p. 581-584
4 p.
|
artikel
|
| 29 |
What can be concluded from the ERSPC and PLCO trial data?
|
Studer, Urs E.
|
|
2010
|
28 |
6 |
p. 668-669
2 p.
|
artikel
|
Tijdschrift beschrijving